MACARTNEY LAWSON 4
4 · Viking Therapeutics, Inc. · Filed Apr 24, 2023
Insider Transaction Report
Form 4
MACARTNEY LAWSON
Director
Transactions
- Exercise/Conversion
Common Stock, par value $0.00001 per share
2023-04-24$3.33/sh+16,000$53,280→ 63,965 total - Exercise/Conversion
Stock Option (Right to Buy)
2023-04-24−16,000→ 0 totalExercise: $3.33From: 2017-01-04Exp: 2026-01-04→ Common Stock (16,000 underlying) - Sale
Common Stock, par value $0.00001 per share
2023-04-24$22.00/sh−16,000$352,061→ 47,965 total
Footnotes (1)
- [F1]The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.